Literature DB >> 3244617

Characterization of the oral absorption of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

P J Sinko1, G L Amidon.   

Abstract

The oral absorption of five cephalosporin antibiotics, cefaclor, cefadroxil, cefatrizine, cephalexin, and cephradine, has been studied using a single-pass intestinal perfusion technique in rats. Intrinsic membrane absorption parameters, "unbiased" by the presence of an aqueous permeability (diffusion or stagnant layer), have been calculated utilizing a boundary layer mathematical model. The resultant intrinsic membrane absorption parameters are consistent with a significant carrier-mediated, Michaelis-Menten-type kinetic mechanism and a small passive component in the jejunum. Cefaclor colon permeability is low and does not exhibit concentration dependent behavior. The measured carrier parameters (+/- SD) for the jejunal perfusions are as follows: cefaclor, J*max = 21.3 (+/- 4.0), Km = 16.1 (+/- 3.6), P*m = 0, and P*c = 1.32 (+/- 0.07); cefadroxil, J*max = 8.4 (+/- 0.8), Km = 5.9 (+/- 0.8), P*m = 0, and P*c = 1.43 (+/- 0.10); cephalexin, J*max = 9.1 (+/- 1.2), Km = 7.2 (+/- 1.2), P*m = 0, and P*c = 1.30 (+/- 0.10); cefatrizine, J*max = 0.73 (+/- 0.19), Km = 0.58 (+/- 0.17), P*m = 0.17 (+/- 0.03), and P*c = 1.25 (+/- 0.10); and cephradine, J*max = 1.57 (+/- 0.84), Km = 1.48 (+/- 0.75), P*m = 0.25 (+/- 0.07), and P*c = 1.06 (+/- 0.08). The colon absorption parameter for cefaclor is P*m = 0.36 (+/- 0.06, where J*max (mM) is the maximal flux, Km (mM) is the Michaelis constant, P*m is the passive membrane permeability, and P*c is the carrier permeability.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244617     DOI: 10.1023/a:1015974920682

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Intestinal absorption aspect of non-lipophilic low molecular weight drugs: a case of cephalexin and cefazolin.

Authors:  M Yasuhara; Y Miyoshi; A Yuasa; T Kimura; S Muranishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-04       Impact factor: 1.645

2.  The intestinal unstirred layer: its surface area and effect on active transport kinetics.

Authors:  F A Wilson; J M Dietschy
Journal:  Biochim Biophys Acta       Date:  1974-08-21

3.  pH-partition behavior of amino acid-like -lactam antibiotics.

Authors:  E D Purich; J L Colaizzi; R I Poust
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

4.  Intestinal absorption mechanisms of ampicillin derivatives in rats. I. Intestinal absorption of ampicillin derivatives.

Authors:  K Miyazaki; O Ogino; M Nakano; T Arita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-02       Impact factor: 1.645

5.  Characterization of aminocephalosporin transport across rat small intestine.

Authors:  T Kimura; T Yamamoto; M Mizuno; Y Suga; S Kitade; H Sezaki
Journal:  J Pharmacobiodyn       Date:  1983-04

6.  Intestinal absorption mechanism of amino-beta-lactam antibiotics. III. Kinetics of carrier-mediated transport across the rat small intestine in situ.

Authors:  E Nakashima; A Tsuji; S Kagatani; T Yamana
Journal:  J Pharmacobiodyn       Date:  1984-07

7.  Transport mechanisms of beta-lactam antibiotics across everted rat gut.

Authors:  S C Penzotti; J W Poole
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

8.  Intestinal absorption of several beta-lactam antibiotics. IV. Binding to the various components in the intestinal mucosa of rat and role in absorption process.

Authors:  K Miyazaki; K Iseki; T Arita
Journal:  J Pharmacobiodyn       Date:  1982-08

9.  Rat jejunum perfused in situ: effect of perfusion rate and intraluminal radius on absorption rate and effective unstirred layer thickness.

Authors:  D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

10.  Comparison of four experimental techniques for studying drug absorption kinetics in the anesthetized rat in situ.

Authors:  N Schurgers; J Bijdendijk; J J Tukker; D J Crommelin
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

View more
  29 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine.

Authors:  Michael B Bolger; Viera Lukacova; Walter S Woltosz
Journal:  AAPS J       Date:  2009-05-12       Impact factor: 4.009

3.  Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data.

Authors:  W R Couet; B G Reigner; J P Guedes; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

4.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

5.  Analysis of intestinal perfusion data for highly permeable drugs using a numerical aqueous resistance--nonlinear regression method.

Authors:  P J Sinko; G D Leesman; A P Waclawski; H Yu; J H Kou
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

6.  Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages.

Authors:  H Yu; T J Cook; P J Sinko
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 7.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

8.  Relevance of PepT1 in the intestinal permeability and oral absorption of cefadroxil.

Authors:  Maria M Posada; David E Smith
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

9.  Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

10.  Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice.

Authors:  Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2016-03-12       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.